Sort   by:  
 Page size 
UnknownIntegrated molecular analysis of Tamoxifen-resistant invasive lobular breast cancer cells identifies MAPK and GRM/mGluR signaling as therapeutic vulnerabilities.
Not available
S-EPMC5858970 | biostudies-literature
UnknownInternal Standard Triggered-Parallel Reaction Monitoring Mass Spectrometry Enables Multiplexed Quantification of Candidate Biomarkers in Plasma.
Not available
S-EPMC9280723 | biostudies-literature
UnknownAbsolute risk prediction of second primary thyroid cancer among 5-year survivors of childhood cancer.
Not available
S-EPMC3530689 | biostudies-literature
UnknownMultiomic analysis identifies CPT1A as a potential therapeutic target in platinum-refractory, high-grade serous ovarian cancer.
Not available
S-EPMC8714940 | biostudies-literature
UnknownEpigenetic loss of AOX1 expression via EZH2 leads to metabolic deregulations and promotes bladder cancer progression.
Not available
S-EPMC8058741 | biostudies-literature
UnknownProteogenomics connects somatic mutations to signalling in breast cancer.
Not available
S-EPMC5102256 | biostudies-literature
UnknownProteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy.
Not available
S-EPMC8077737 | biostudies-literature
UnknownProteogenomic analysis of chemo-refractory high-grade serous ovarian cancer.
Not available
S-EPMC10414761 | biostudies-literature
UnknownAnalytical validation of a standardized scoring protocol for Ki67: phase 3 of an international multicenter collaboration.
Not available
S-EPMC5515324 | biostudies-literature
UnknownPDX-MI: Minimal Information for Patient-Derived Tumor Xenograft Models.
Not available
S-EPMC5738926 | biostudies-literature
Sort   by:  
 Page size